The very foundation of Fusetec was based on the research question - "How do surgeons train?"
Traditional training provides surgical skills training through cadaver workshops or in the operating theatre. However, the inherent variability between individuals presents a challenge in standardization and assessing skill levels in a quantifiable way. Coupled with the risk associated with training on both living patients and the risk of potentially harmful bacteria and or toxic gases when dissecting cadavers, leaves a gap in the surgical training needs.
Fusetec is an intellectual property (IP) centric company that designs and manufactures anatomically accurate, fully operable, soft tissue surgical training models. These advanced models provide a paradigm shift in surgical training.
Fusetec’s quest to answer the research question has been a battle hard fought. Once the vision and strategic plan had been identified, the founding partners collaborated with Universities and key opinion leaders (KOLs) to assemble the research team to develop the science needed for this ambitious task.
After several years of research and development, Fusetec introduced the first range of ENT trainers. These were developed under the guidance of Professor Peter-John Wormald. Professor Wormald and Fusetec would meet every Tuesday afternoon to track progress and set the agenda for the following week’s advancements of technologies.
The inaugural launch was in autumn 2019 at the Masterclass in Endoscopic Sinus Surgery course (McGill University. Montreal, Canada) followed by training courses in Australia and Japan.
During the COVID-19 pandemic, Fusetec continued developing new products. The current catalogue include models which have simulated pathology such as inverted papilloma and pituitary tumours.
Being an IP-centric company, Fusetec’s developments will continue; driven by the singular vision to advance surgical training with the ultimate goal of improving patient outcomes.